Abdominal Aortic Aneurysm Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB

DelveInsight's "Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Abdominal Aortic Aneurysm market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Abdominal Aortic Aneurysm Market Forecast
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Abdominal Aortic Aneurysm Market Report:
• The Abdominal Aortic Aneurysm market size was valued approximately USD 1579.9 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In January 2024, Arizona-headquartered Nectro Medical launched a Phase II/III clinical trial to assess the safety and effectiveness of its endovascular aneurysm stabilization treatment (Nectero EAST). Nectero EAST comprises a single-use endovascular system consisting of a dual-balloon delivery catheter and a stabilizing solution containing pentagalloyl glucose (PGG). When administered locally, PGG has the potential to bind to elastin and collagen, potentially reinforcing the aortic wall. Animal studies have demonstrated that PGG can impede the progression of abdominal aortic aneurysm (AAA).
• The overall number of diagnosed cases of Abdominal Aortic Aneurysm (AAA) across seven major markets (7MM) was approximately 1,641,380 cases in 2021 and is anticipated to rise over the study duration from 2019 to 2032. Specifically, the United States accounted for the highest number of diagnosed cases, estimated at 752,408 cases in 2021, among all the countries included in the 7MM.
• In the European Union's five nations, Germany has the highest total prevalent population of Abdominal Aortic Aneurysm (AAA) with 192,532 cases, followed by France with 138,193 cases. Italy, on the other hand, recorded the lowest prevalent cases among the EU-5 countries, with 68,202 cases.
• The total prevalent population of Abdominal Aortic Aneurysm (AAA) in Japan was estimated to be 253,883 cases in 2021 and is projected to decline during the forecast period from 2023 to 2032.
• In the United States, 200,000 persons are diagnosed with an abdominal aortic aneurysm (AAA) annually
• Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Nectero Medical LLC, Cardiatis, SA, Endologix LLC, RSPR Pharma AB, and others
• Key Abdominal Aortic Aneurysm Therapies: Nectero EAST System, Bifurcated MFM, Chimney EndoVascularAneurysm Sealing system, Ticagrelor, CRD007, and others
• The Abdominal Aortic Aneurysm epidemiology based on gender analyzed that Abdominal aortic aneurysms are more common in men
• The Abdominal Aortic Aneurysm market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics.

Abdominal Aortic Aneurysm Overview
An abdominal aortic aneurysm (AAA) is a localized enlargement or bulging of the abdominal aorta, the main blood vessel that supplies blood to the body, particularly the lower extremities. This enlargement typically occurs below the kidneys, in the portion of the aorta that runs through the abdomen.

Get a Free sample for the Abdominal Aortic Aneurysm Market Report:
https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Abdominal Aortic Aneurysm Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Abdominal Aortic Aneurysm Epidemiology Segmentation:
The Abdominal Aortic Aneurysm market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Abdominal Aortic Aneurysm
• Prevalent Cases of Abdominal Aortic Aneurysm by severity
• Gender-specific Prevalence of Abdominal Aortic Aneurysm
• Diagnosed Cases of Episodic and Chronic Abdominal Aortic Aneurysm

Download the report to understand which factors are driving Abdominal Aortic Aneurysm epidemiology trends @ Abdominal Aortic Aneurysm Epidemiology Forecast
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Abdominal Aortic Aneurysm Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Abdominal Aortic Aneurysm market or expected to get launched during the study period. The analysis covers Abdominal Aortic Aneurysm market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Abdominal Aortic Aneurysm Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Abdominal Aortic Aneurysm Therapies and Key Companies
• Nectero EAST System: Nectero Medical LLC
• BifurcatedMFM: Cardiatis, SA
• Chimney EndoVascularAneurysm Sealing system: Endologix LLC
• Ticagrelor: Nectero Medical LLC
• CRD007: RSPR Pharma AB

To know more about Abdominal Aortic Aneurysm companies working in the treatment market, visit @ Abdominal Aortic Aneurysm Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Abdominal Aortic Aneurysm Market Strengths
• This condition is present in ≈2% of the elderly population,with ≈150 000 new cases diagnosed each year, and the incidence is increasing.
• In the last few years, all major aortic endograft companies have developed renewed models of grafts and/or delivery systems to cope with difficult anatomies and guarantee better delivery, more precise deployment, and improved performance.
Abdominal Aortic Aneurysm Market Opportunities
• Increasing geriatric population base and prevalence of AAA disease in the western countries provides a lucrative opportunity for the market.
• Increasing efforts to develop and discover drugs and devices that could potentially treat the disease
Scope of the Abdominal Aortic Aneurysm Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Medtronic, RSPR Pharma AB, Nectero Medical LLC, Cardiatis, SA, Endologix LLC, RSPR Pharma AB, and others
• Key Abdominal Aortic Aneurysm Therapies: Nectero EAST System, Bifurcated MFM, Chimney EndoVascularAneurysm Sealing system, Ticagrelor, CRD007, and others
• Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
• Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Abdominal Aortic Aneurysm Unmet Needs, KOL's views, Analyst's views, Abdominal Aortic Aneurysm Market Access and Reimbursement

Discover more about therapies set to grab major Abdominal Aortic Aneurysm market share @ Abdominal Aortic Aneurysm Treatment Market
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Abdominal Aortic Aneurysm Market Report Introduction
2. Executive Summary for Abdominal Aortic Aneurysm
3. SWOT analysis of Abdominal Aortic Aneurysm
4. Abdominal Aortic Aneurysm Patient Share (%) Overview at a Glance
5. Abdominal Aortic Aneurysm Market Overview at a Glance
6. Abdominal Aortic Aneurysm Disease Background and Overview
7. Abdominal Aortic Aneurysm Epidemiology and Patient Population
8. Country-Specific Patient Population of Abdominal Aortic Aneurysm
9. Abdominal Aortic Aneurysm Current Treatment and Medical Practices
10. Abdominal Aortic Aneurysm Unmet Needs
11. Abdominal Aortic Aneurysm Emerging Therapies
12. Abdominal Aortic Aneurysm Market Outlook
13. Country-Wise Abdominal Aortic Aneurysm Market Analysis (2019-2032)
14. Abdominal Aortic Aneurysm Market Access and Reimbursement of Therapies
15. Abdominal Aortic Aneurysm Market Drivers
16. Abdominal Aortic Aneurysm Market Barriers
17. Abdominal Aortic Aneurysm Appendix
18. Abdominal Aortic Aneurysm Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Latest Reports Offered By DelveInsight:

Iga Nephropathy Market
https://www.delveinsight.com/report-store/iga-nephropathy-market
DelveInsight's "IgA Nephropathy Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of the IgA Nephropathy, historical and forecasted epidemiology as well as the IgA Nephropathy market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, Japan, and China.
Vutrisiran Market
https://www.delveinsight.com/report-store/vutrisiran-market
DelveInsight's "Vutrisiran Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Vutrisiran, historical and forecasted epidemiology as well as the Vutrisiran market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastroesophageal Reflux Disease Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market
DelveInsight's "Gastroesophageal Reflux Disease (GERD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastroesophageal Reflux Disease (GERD), historical and forecasted epidemiology as well as the Gastroesophageal Reflux Disease (GERD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
DelveInsight's 'Cerebral Palsy Market Insights, Epidemiology, and Market Forecast 2032' report delivers an in-depth understanding of cerebral palsy, historical and forecasted epidemiology as well as cerebral palsy market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Granulomatosis With Polyangiitis Market
https://www.delveinsight.com/report-store/granulomatosis-with-polyangiitis-market
DelveInsight's "Granulomatosis With Polyangiitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Granulomatosis With Polyangiitis, historical and forecasted epidemiology as well as the Granulomatosis With Polyangiitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Hemophilia A Market
https://www.delveinsight.com/report-store/hemophilia-a2030-market
DelveInsight's "Hemophilia A Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Hemophilia A, historical and forecasted epidemiology as well as the Hemophilia A market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Graft Versus Host Disease Market https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
DelveInsight's "Graft Versus Host Disease (GvHD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Graft Versus Host Disease, historical and forecasted epidemiology as well as the Graft Versus Host Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Hemorrhoids Market
https://www.delveinsight.com/report-store/hemorrhoids-market
DelveInsight's "Hemorrhoids Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Hemorrhoids, historical and forecasted epidemiology as well as the Hemorrhoids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Asthma Market
https://www.delveinsight.com/report-store/asthma-market
DelveInsight's "Asthma - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Asthma market trends in the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan.

Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
DelveInsight's "Myelodysplastic Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Myelodysplastic Syndrome, historical and forecasted epidemiology as well as the Myelodysplastic Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.